Company Quick10K Filing
Canfield Medical Supply
10-Q 2020-03-31 Filed 2020-05-13
10-K 2019-12-31 Filed 2020-03-27
10-Q 2019-09-30 Filed 2019-11-14
10-Q 2019-06-30 Filed 2019-08-14
10-Q 2019-03-31 Filed 2019-05-21
10-K 2018-12-31 Filed 2019-03-29
10-Q 2018-09-30 Filed 2018-11-14
10-Q 2018-06-30 Filed 2018-08-20
10-Q 2018-03-31 Filed 2018-05-15
10-K 2017-12-31 Filed 2018-04-02
10-Q 2017-09-30 Filed 2017-11-13
10-Q 2017-06-30 Filed 2017-08-18
10-Q 2017-03-31 Filed 2017-05-18
10-K 2016-12-31 Filed 2017-03-28
10-Q 2016-09-30 Filed 2016-11-21
10-Q 2016-06-30 Filed 2016-11-15
10-Q 2016-03-31 Filed 2016-11-15
10-K 2015-12-31 Filed 2016-10-03
10-Q 2015-09-30 Filed 2016-10-27
10-Q 2015-06-30 Filed 2016-10-14
10-Q 2015-03-31 Filed 2016-10-11
10-K 2014-12-31 Filed 2016-09-21
10-Q 2014-09-30 Filed 2014-11-19
10-Q 2014-06-30 Filed 2014-08-19
10-Q 2014-03-31 Filed 2014-05-20
10-K 2013-12-31 Filed 2014-04-15
10-Q 2013-09-30 Filed 2013-11-13
10-Q 2013-06-30 Filed 2013-08-02
10-K 2012-12-31 Filed 2013-04-15
8-K 2020-04-17 Accountant, Officers, Exhibits
8-K 2020-03-31 Regulation FD, Other Events, Exhibits
8-K 2019-12-31 Enter Agreement, Exhibits
8-K 2019-11-26 Officers, Exhibits
8-K 2019-11-19 Officers
8-K 2019-06-28 Control, Officers, Amend Bylaw
8-K 2019-06-21 Sale of Shares, Control, Exhibits
8-K 2018-01-22 Accountant, Exhibits

Canfield Medical Supply Financials

CMDS Metrics, Comps, Filings

Quarterly | Annual

Business

Canfield Medical Supply, Inc. ("the Company", "it", "we', "us" or "our") was incorporated in the State of Ohio on September 3, 1992. On April 18, 2012 it changed its domicile to the State of Colorado by merging with a newly formed Colorado subsidiary.

We commenced our operations in September 1992. Initially we operated as a compounding pharmacy providing Intradialytic Parenteral Nutrition (a means of providing additional nutrition to patients on dialysis) to patients with End Stage Renal Disease who had experienced excessive weight loss due to intestinal malabsorption. We also provided pharmacy services to patients who required intravenous antibiotic therapy, home total parenteral nutrition and home enteral nutrition. (Enteral nutrition involves absorption of the drug through the gastrointestinal tract and parenteral nutrition involves administering the drug/nutrition in some way other than the digestive tract.) We also provided various nebulizer medications for patients with chronic obstructive pulmonary disease. (A nebulizer is a device used to administer medication in the form of a mist inhaled into the lungs.) We ceased pharmacy operations in May 2002 in response to significant reductions in reimbursement by Medicare, Medicaid and Private Insurance Companies, and changed our focus to providing quality home medical equipment and supplies to patients in our geographical area.

We are a provider of home medical equipment, supplies and services (which relate to the equipment sales) in Ohio's Mahoning Valley, with an emphasis on providing for patients with mobility related limitations. We also sell to patients in Western Pennsylvania and Northern West Virginia. We typically provide equipment, supplies and services to people who have had strokes, hip or knee replacements, and other surgeries after they are discharged from a hospital or rehab center. We provide almost any medical equipment and supplies these persons need to enable them to remain in their homes. We have been in the home health care business since 1992 and have developed relationships with many of the local physicians, discharge planners for hospitals and rehab facilities, nursing services, and home health agencies.


Valuation ($)

Market Cap, Enterprise Value

Balance Sheet ($)

Assets, Equity

Income Statement ($ Quarterly)

Revenue, G Profit, Net Income

Cash Flow ($ Quarterly)

Ops, Inv, Fin

Comps ($ TTM) Market Cap Gross Margin EV/EBITDA Ret on Assets Assets Liabilities Revenue G Profit Net Income EBITDA EV
Stemcell Holdings (STMM) 113% -1.0 26% 12,032,848,000 6,023,444,000 7,313,554,000 8,234,525,000 3,099,084,000 4,927,199,000 -5,115,749,000
FCCC (FCCC) 1.5 -61% 92,000,000 3,000,000 0 0 -56,000,000 -56,000,000 -82,002,000
Tapinator (TAPM) 0% 0.1 -99% 1,783,274,000 951,832,000 4,322,948,000 0 -1,761,567,000 -1,761,567,000 -260,211,000
Nogales Resources (NLRT) 0% 517,000 187,974,000 0 0 0 0 -519,000
Golden Growers Cooperative (GGRO) -0% 0% 26,919,000,000 2,171,000,000 42,425,000,000 -45,000,000 0 0 -3,508,002,000
Northern Power Systems (NPS) 22% 0.4 -27% 8,927,000,000 13,901,000,000 18,317,000,000 4,050,000,000 -2,379,000,000 -1,701,000,000 -670,002,000
Twin River Worldwide (TRWH) 0% 4.0 4% 1,070,918,000,000 808,153,000,000 393,158,000,000 0 41,775,000,000 112,100,000,000 449,559,999,000
Bio-En (BENH) 0.1 -643% 10,396,000 149,279,000 0 0 -66,818,000 -66,818,000 -4,687,000
Southwest Iowa Renewable Energy (SIRE) -1% -47.3 -1% 140,863,000,000 51,558,000,000 216,993,000,000 -1,931,000,000 -1,169,518,000 -536,518,000 25,395,999,000
Texas Republic Capital (TRCC) 0% 8.9 -5% 26,314,961,000 14,988,148,000 930,677,000 0 -1,274,149,000 -1,274,149,000 -11,327,584,000
Fannie Mae (FNM) 28.1 0% 3,494,436,000,000,000 3,484,094,000,000,000 0 0 13,025,000,000,000 119,732,000,000,000 3,361,547,999,999,000
CBA Florida (CBAI) 43.6 -1% 14,544,469,000 597,854,000 0 0 -210,911,000 -260,844,000 -11,367,563,000
Pacific Gold & Royalty (PCFG) -7.1 0 3,799,496,000 0 -2,545,000 -238,328,000 -45,194,000 319,839,000
BoxScore Brands (BOXS) 33% -8.3 -540% 312,912,000 7,564,280,000 338,295,000 110,302,000 -1,690,277,000 -701,925,000 5,793,309,000
Quest Management (QUEST) 27% -0.3 129% 12,526,000 6,028,000 45,177,000 12,318,000 16,132,000 16,164,000 -5,306,000
Zhen Ding Resources (RBTK) 0.1 48,309,900% 0 0 -483,099,000 -68,261,000 -6,097,000
Hines Global REIT (HGRI) 0% 1.7 19% 2,010,946,000,000 999,520,000,000 205,149,000,000 0 388,366,000,000 421,651,000,000 715,766,999,000
Wadena (WDN) 0% 0.0 -2,344% 11,999,000 696,137,000 87,000,000 0 -281,214,000 -278,021,000 -5,132,000
Galera Therapeutics (GRTX) 1.3 -17% 79,758,000,000 52,298,000,000 0 0 -13,351,000,000 -12,433,000,000 -15,719,002,000
Chase General (CSGN) 26% -0.5 -2% 1,563,342,000 1,016,098,000 2,493,194,000 657,636,000 -32,054,000 13,371,000 -6,929,000

Balance Sheet ($)2013-03-312013-06-302013-09-302014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Cash5,070,0006,012,00028,888,00051,701,00038,440,00024,908,00011,052,0008,914,0006,499,0007,343,00085,253,00037,177,00034,742,00061,659,00040,431,0009,559,00037,281,00017,921,00030,208,00033,298,00021,680,0006,980,00019,830,000235,324,00077,602,000
Accounts Receivable19,668,00016,497,00046,162,00039,987,00069,238,00080,183,000108,827,000120,723,00089,138,000167,063,000141,702,000142,624,000151,176,000206,254,000177,183,000182,904,000231,010,000151,262,000248,354,000226,350,000267,900,000300,993,000290,616,000205,565,000320,465,000
Inventory
PP&E21,364,00038,106,00047,309,00042,575,00040,519,00040,467,00043,753,00052,988,00047,446,00062,066,000138,387,00063,533,00060,989,00056,155,000139,794,00046,615,00040,871,00043,678,000151,534,00049,107,00044,393,00042,341,000
Assets24,738,00022,509,00075,050,000131,240,000181,201,000166,714,000171,030,000182,884,000148,760,000239,748,000306,115,000254,165,000274,825,000355,334,000315,697,000291,014,000353,483,000241,028,000360,052,000335,217,000350,702,000408,295,000421,954,000553,052,000500,786,000
Accounts Payable22,680,00028,542,00036,293,00039,542,00052,915,00071,275,00078,738,000108,473,00096,113,000135,211,000142,627,000127,817,000148,637,000209,069,000226,210,000331,034,000366,718,000235,264,000318,185,000
Long-Term Debt19,650,00037,932,00035,825,00034,313,00032,481,00030,634,00028,772,00026,894,00025,002,00038,894,00036,223,00033,527,00030,810,00028,069,00025,305,00022,166,00019,704,00016,600,00013,739,00010,578,0008,288,0006,057,000
Liabilities121,227,000126,042,000127,043,000140,192,000171,347,000187,352,000192,551,000219,954,000204,747,000241,233,000245,521,000226,819,000259,333,000315,665,000302,946,000297,395,000324,456,000313,893,000412,909,000320,366,000338,845,000410,954,000478,949,000617,091,000618,802,000
Stockholders' Equity-96,489,000-103,533,000-51,993,000-8,952,0009,854,000-20,638,000-21,521,000-37,070,000-55,987,000-1,485,00060,594,00027,346,00015,492,00039,669,00012,751,000-6,381,00029,027,000-72,865,000-52,857,00014,851,00011,857,000-2,659,000-56,995,000-64,039,000-118,016,000
Income Statement ($)2013-03-312013-06-302013-09-302014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Revenue73,354,00082,366,000141,849,000157,992,000165,188,000140,876,000211,879,000261,217,000219,105,000277,281,000259,653,000199,985,000236,059,000316,594,000210,060,000210,572,000319,015,000155,699,000344,624,000354,765,000312,988,000271,955,000174,947,000305,197,000
Cost of Revenue29,025,00040,847,00078,520,00053,042,00053,782,00070,716,00091,965,000141,197,000119,075,000112,926,000126,310,000108,804,000113,572,000136,222,000105,521,00088,849,000148,664,00097,383,000170,176,000147,035,000147,911,000132,395,000117,351,000143,348,000
Gross Profit44,329,00041,519,00063,329,000104,950,000111,406,00070,160,000119,914,000120,020,000100,030,000164,355,000133,343,00091,181,000122,487,000180,372,000104,539,000121,723,000170,351,00058,316,000174,448,000211,827,000165,077,000139,560,00057,596,000161,849,000
R&D
SG&A49,915,00047,487,00073,335,00084,886,00089,428,000
Tax000000000000000000000000
Net Income-6,167,000-7,044,000-11,160,00020,483,00018,806,000-58,218,000-883,000-9,788,000-18,917,00054,502,00012,079,000-33,248,000-11,854,000-15,823,000-61,918,000-19,132,00035,408,000-101,892,00020,008,00067,708,000-4,994,000-54,336,000-107,044,000-53,977,000
Cash Flow ($)2013-03-312013-06-302013-09-302014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Cash Operating-1,782,000-5,558,000-33,074,000-11,596,00019,209,000-9,583,0003,460,00014,077,00049,325,0004,857,000-38,234,000-7,487,00038,160,000-10,036,00024,642,00018,870,0009,877,00024,583,000-150,730,000-68,083,000
Cash Investing0000-30,387,000-2,009,000-4,689,000-10,621,000-18,287,000-13,840,000-13,208,000-18,640,000-6,061,000-4,319,000-7,363,000-11,521,000-18,646,000-6,606,000-9,612,000-14,669,000
Cash Financing-500,0006,500,00055,950,000-1,665,000-2,354,000-2,264,000-2,332,000-2,612,00046,872,00035,900,00030,214,000-4,745,000-4,377,000-5,005,000-4,992,000-4,259,000-2,849,000-5,127,000375,836,000-74,970,000